Zopapogene imadenovec is a non-replicating adenoviral vector-based immunotherapy designed to induce an immune response against HPV 6 and HPV 11 proteins.

Prevalence of glycemic control and use of diabetes technology lowest in Hispanic, non-Hispanic Black, Medicaid-insured.

FluMist is delivered in a temperature-controlled package with at-home specific instructions on the proper handling, administration, and disposal of the vaccine.

Treatment linked to reduced rates of first occurrence of suicidal behaviors, substance misuse, transport accidents, criminality.

The updated recommendations also address the link between high blood pressure and cognitive decline and dementia.

Nerve stimulation device cleared for sleep apnea; Skysona safety update; new non-cystic fibrosis bronchiectasis treatment; FDA cracks down on animal-derived thyroid meds; RSV therapy to be ...

Thirty-four point three and 37.6% of US adults were reportedly unaware of HPV and lacked awareness about the HPV vaccine, respectively.

The sodium chloride 0.9% injection shortage is resolved, and it will be removed from the FDA Drug Shortage Database; facilities are advised to use FDA-approved products when available. The FDA is ...

HLD-0915 is a RIPTAC therapeutic designed to selectively target prostate cancer tumor cells by binding together the androgen receptor with an essential effector protein.

Future prospective studies will be necessary to assess potential causation of sucralose in driving immunotherapy resistance as well as to determine how other demographic factors, including location ...

Independent factors tied to adenoma detection rate include AI exposure, male versus female patient sex, patient age 60 years or older vs younger than 60.